Stay updated on Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.6, indicating a small platform-level update. It does not change trial details, eligibility criteria, outcomes, or other substantive content on the study page.
    Difference
    0.1%
    Check dated 2026-08-31T18:28:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study's external identifiers now include an NIH funding reference for 2017, adding funding attribution to the record.
    Difference
    0.1%
    Check dated 2026-08-24T19:10:51.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a new revision version (v3.6.5) replacing the previous one, indicating a release update. This update pertains to the site's software layer rather than the clinical trial data or public text.
    Difference
    0.1%
    Check dated 2026-08-10T12:43:58.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows a new revision tag 'Revision: v3.6.4' replacing the previous 'Revision: v3.6.3'. This indicates a minor update to the study record page's metadata rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-07-27T06:19:18.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a new page build. The change does not modify study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-05T13:26:23.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.6.2 instead of v3.6.0, indicating a minor update to the site interface.
    Difference
    0.1%
    Check dated 2026-06-28T08:44:55.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.